|
| 3 months evaluation N = 74 | Evaluation after end of adjuvant treatment N = 74 | Statistical significance# | ||
| Improvement | Deterioration | Improvement | Deterioration | P value* | |
| No (%) | No (%) | No (%) | No (%) |
| |
| Breast size | 10 (13.5) | 6 (8.2) | 11 (14.9) | 4 (5.4) | 0.35 |
| Breast shape | 17 (23.0) | 19 (25.7) | 17 (23) | 18 (24.3) | 0.43 |
| Scar visibility | 2 (2.7) | 6 (8.4) | 2 (2.7) | 6 (8.4) | 0.16 |
| Nipple position | 10 (13.5) | 6 (8.4) | 10 (13.5) | 5 (6.8) | 0.16 |
| Skin color | 4 (5.4) | 1 (1.35) | 4 (5.4) | Zero (0) | 0.046 |
| Donor site | 74 (100) | Zero (0) | 74 (100) | Zero (0) | < 0.001 |